Henry Schein shares rose 0.9% to $86.48 at the latest close. The latest filing gives investors a business that sold more, earned more, and kept slightly more of each sales dollar, with one less-comfortable detail tucked into the working capital lines.
Revenue rose 6.7% to $3.5 billion in the three months ended June 27. Gross profit grew 8.4%, operating income grew 13.2% to $171 million, and diluted EPS rose 17.1% to $0.82. The per-share number also got help from a 6.7% reduction in diluted shares.
The stronger operating result came with more money tied up in the business. Inventory rose 7.9% to $2.1 billion, while accounts receivable increased 7.2% to $1.8 billion. Inventory therefore grew faster than sales, and the company’s cash-flow margin slipped 0.1 percentage points even as lower capital spending helped cash generation.
Management attributes the sales increase to merchandise, dental equipment, and value-added services, including practice transitions. Its explanation is specific, but it also shows why the headline growth rate does not settle the cash question.
"The 4.1% increase in internally generated local currency dental sales was primarily due to merchandise sales growth in U.S. and international markets, growth in traditional dental equipment in the U.S. and international markets, and value-added services sales attributable to increased sales in our practice transitions business."
Henry Schein, 10-Q filed August 4, 2026
That is growth across several parts of the dental business, rather than a single product doing all the lifting. The balance sheet still absorbed more inventory and receivables than the sales line did.
The margin improvement was real, if narrow: gross margin moved from 31.4% to 31.8%, and operating margin from 4.7% to 4.9%. Net margin stayed roughly flat at 2.7%, partly because interest expense rose as borrowings increased.
"Interest expense increased primarily due to increased borrowings."
Henry Schein, 10-Q filed August 4, 2026
The plain-English version is that Henry Schein converted more sales into operating profit, but the financing bill took a larger slice below that line. For a distributor, where operating margin is measured in single digits, a few basis points of movement do not need much drama to matter.
The company’s annual record supplies some context without turning this into a different story. Revenue grew 4.0% in 2025, while operating margin was 5.0%, close to the 4.9% reported for the latest three months. The current filing is therefore stronger on sales growth than the recent annual baseline, while the latest operating margin was close to the recent annual baseline.
Henry Schein also says tariffs had no material adverse impact through the first six months of 2026, though tariff uncertainty temporarily affected U.S. dental-equipment sales in the comparable period. That removes one disclosed headwind from the current comparison, while leaving the inventory, receivables, and borrowing figures as the more immediate pieces to reconcile.
Henry Schein’s next quarterly report will add the useful receipt: whether inventory and receivables are growing more slowly than sales, and how borrowings and interest expense have moved alongside them. For now, the filing’s trade-off is simple enough: more business, more stock on hand, and a slightly larger bill for the money behind it.
Henry Schein’s latest 10-Q describes faster sales growth with a bigger working-capital and interest bill.